The way we see it
Oxford BioMedica annual report 2012
Our third annual report and accounts for Oxford BioMedica explains to investors the way they see it.
thinkerdoer helped craft identify and key messages and created striking billboard style pages between the statutory reporting. Bespoke photography by Philip Gatward tied together the progress of OXB's ocular gene therapy products with wider strategic objectives; seeing value in the future of the sector, and seeing how to turn their cutting edge science into commercial reality.
These annual report and accounts for this FTSE Pharmaceuticals and Biotechnology sector listed company are in our opinion, and that of the analysts we speak to among the best in class.